This study could potentially impact the stock performance of Regeneron Pharmaceuticals and Sanofi, as positive results may enhance investor sentiment and market valuation. The study’s focus on COPD, a ...

Return on Equity (ROE): Regeneron Pharmaceuticals's financial strength is reflected in its exceptional ROE, which exceeds ...

Amazon.com reports its second-quarter earnings on Thursday after the market close. Wall Street analysts expect continued ...

As August 5 approaches, Amgen (AMGN) gears up to reveal its Q2 2025 earnings after market close, and expectations are high ...

Biotech company Regeneron (NASDAQ:REGN) will be reporting earnings this Friday before market open. Here’s what investors should know. Regeneron missed analysts’ revenue expectations by 6.1% last ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

John G Ullman & Associates Inc. made a hefty bet on Regeneron Pharmaceuticals, upping their stake by a whopping 94%, now ...

Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

QuantumScape's Q2 2025 highlights breakthroughs in battery tech and long-term EV market potential. Read more on why I recommend QS to be bought on dips and holding long.

Schlumberger Q2 2025 Earnings Preview: Weak drilling activity, sector headwinds to weigh Jul. 17, 2025 10:25 AM ET Schlumberger Limited (SLB) Stock SP500 By: Khushi Singh, SA News Editor 1 Comment ...

Hexcel (HXL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

Sallie Mae (SLM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a ...